Solid Organ Transplantation Pharmacy

Solid Organ Transplantation Pharmacists provide evidence-based, patient-centered medication therapy management and care for patients throughout all phases of solid organ transplantation at all ages and in various healthcare settings.

The BPS Board Certified Transplant Pharmacist® (BCTXP) program is a credential for pharmacists who have met the eligibility criteria below and specialize in the delivery of direct patient care, as members of interprofessional health care teams, working to ensure safe and effective use of medications for patients throughout all phases of solid organ transplantation.

The purpose of the BPS Board Certified Transplant Pharmacist® (BCTXP) program is to validate that the pharmacist has the advanced knowledge and experience to optimize patient outcomes by:

  • Managing complex medication regimens unique to the solid organ transplant population
  • Providing evidence-based, patient-centered medication management
  • Designing, implementing, monitoring, and modifying pharmacotherapeutic plans to improve safety and efficacy
  • Analyzing and reevaluating multifaceted clinical and outcomes data to improve patient care
  • Demonstrating ongoing quality assessment and process improvement as required by regulatory agencies
  • Facilitating medication adherence and pharmacotherapy education

Pharmacists who meet all of the eligibility criteria including passing the examination will be awarded the credential titled: Board Certified Transplant Pharmacist® (BCTXP).

Effective January 1, 2019: All applicants intending to demonstrate eligibility for any BPS certification examination utilizing the practice experience pathway must provide an attestation from their employer, on company letterhead, that verifies this experience accurately represents 50% of time spent in some or all of the activities defined by the applicable certification content outline. In addition, this practice experience must have occurred within the seven years immediately preceding the application. For more information, click here.

(All practice eligibility requirements must be met prior to the candidate sitting for the examination)

The minimum requirements for the Solid Organ Transplantation Pharmacy specialty certification are:

  • Graduation from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in the jurisdiction.
  • A current, active license/registration to practice pharmacy in the U.S. or another jurisdiction.
  • Demonstration of practice experience in one of three ways:

Completion of four (4) years of practice experience** (i.e., four years of experience after licensure/registration as a pharmacist) including 50% or more of that time spent practicing in the domains described in the Solid Organ Transplantation Pharmacy Content Outline

OR

Completion of a PGY-1 residency* plus two (2) additional years of practice experience**(i.e., two years of experience after licensure/registration as a pharmacist) including 50% or more of time spent practicing in the domains described in the Solid Organ Transplantation Pharmacy Content Outline

OR

Completion of a specialty (PGY-2) residency* in Solid Organ Transplantation Pharmacy; and

  • Achieving a passing score on the Solid Organ Transplantation Pharmacy Specialty Certification Examination.

*Effective January 1, 2013, only residency programs accredited by the American Society of Health-System Pharmacists (ASHP) and completed by the applicant within the past 7 years, or new residency programs granted Candidate Status for accreditation by ASHP are creditable for this purpose.

**Practice experience should be from within the past seven years prior to the application date.

The rationale for the appropriateness of the requirements for BPS certification programs are based upon the following:

  • BPS recognizes individuals who graduate from a recognized school or college of pharmacy within the candidate’s jurisdiction. Those jurisdictions recognize and evaluate programs on the extent to which it accomplishes its stated goals and is consistent with the concept that pharmacy is a unique, personal service profession in the health science field. In the United States, the responsibility for responsibility recognizing schools and colleges of pharmacy falls to the Accreditation Council for Pharmacy Education (ACPE).
  • The rationale for requiring licensure or registration of pharmacists within their jurisdiction is based upon the fact that for public protection, all pharmacists must be licensed or registered. This is considered a baseline requirement to be a pharmacist specialist. In the United States, BPS recognizes the licensure process administered by the National Association of Boards of Pharmacy (NABP). The National Association of Boards of Pharmacy (NABP) aims to ensure the public’s health and safety through its pharmacist license transfer and pharmacist competence assessment programs. NABP’s member boards of pharmacy are grouped into eight districts that include all 50 United States, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, Australia, Bahamas, and all 10 Canadian provinces.
  • The experiential component is required to help assure practical application of components of the specialty knowledge being certified. There are multiple pathways to meet the practice experience requirement.  The faster eligibility pathways recognize accredited residencies through the American Society of Health System Pharmacists (ASHP). The ASHP residency accreditation program identifies and grants public recognition to practice sites having pharmacy residency training programs that have been evaluated and found to meet the qualifications of one of the ASHP’s residency accreditations standards. Thus, accreditation of a pharmacy residency program provides a means of assurance to residency applicants that a program meets certain basic requirements and is, therefore, an acceptable site for postgraduate training in pharmacy practice in organized health care.
  • Passing the BPS pharmacy specialty examination helps assure knowledge consistent with the validated content outline for the BPS specialty.

The appropriateness of the BPS program requirements are consistent with the Council on Credentialing in Pharmacy’s Resource Paper titled: Scope of Contemporary Pharmacy Practice: Roles, Responsibilities, and Functions of Pharmacists and Pharmacy Technicians.

  • Domain 1: Clinical Skills and Therapeutic Management  (65% of the examination)
  • Domain 2: Administration and Practice Development (15% of the examination)
  • Domain 3: Information Management and Education  (15% of the examination)
  • Domain 4: Public Health (5% of the examination)

Pharmacists who earn the designation Board Certified Transplant Pharmacist® (BCTXP) will be required to maintain their certification over a seven year period by completing one of the following professional development activities:

  • Option One: Examination
    Achieving a passing score on the 100-item recertification examination (administered by BPS), based on the content outline for the Solid Organ Transplantation Pharmacy Specialty in their seventh year following initial certification;

OR

  • Option Two: Continuing Education
    Earning 100 hours of continuing education credit** provided by a professional development program approved by BPS.

Board Certified Transplant Pharmacists® are also required to pay the BPS Annual Certification Maintenance Fee of $125 each year for years one through six and a $400 recertification fee in year seven. Individuals with more than one BPS certification will only be assessed one BPS Annual Certification Maintenance Fee each year.

Download PDF Fact Sheet

 

Solid Organ Transplantation Pharmacists provide evidence-based, patient-centered medication therapy management and care for patients throughout all phases of solid organ transplantation at all ages and in various healthcare settings.

The BPS Board Certified Transplant Pharmacist® (BCTXP) has the advanced knowledge and experience to optimize patient outcomes by:

  • Managing complex medication regimens unique to the solid organ transplant population
  • Providing evidence-based, patient-centered medication management
  • Designing, implementing, monitoring, and modifying pharmacotherapeutic plans to improve safety and efficacy
  • Analyzing and reevaluating multifaceted clinical and outcomes data to improve patient care
  • Demonstrating ongoing quality assessment and process improvement as required by regulatory agencies
  • Facilitating medication adherence and pharmacotherapy education

To become a BPS Board Certified Transplant Pharmacist®, a pharmacist must:

  • Graduate from a pharmacy program accredited by the Accreditation Council for Pharmacy Education (ACPE) or a program outside the U.S. that qualifies the individual to practice in that jurisdiction; and
  • Maintain an active license to practice pharmacy in the U.S. or another jurisdiction; and
  • Complete four (4) years of post-licensure practice experience with at least fifty percent (50%) of time spent in solid organ transplantation pharmacy activities as defined in the BPS Solid Organ Transplantation Pharmacy Specialty Content Outline; or
  • Complete a PGY-1 residency accredited by the American Society of Health-System Pharmacists (ASHP) or new residency programs granted Candidate Status for accreditation by ASHP plus two additional years of post-licensure practice with at least fifty percent (50%) of time spent in solid organ transplantation pharmacy activities as defined in the BPS Solid Organ Transplantation Pharmacy Specialty Content Outline; or
  • Complete an ASHP-accredited PGY-2 residency in Solid Organ TransplantationPharmacy; and
  • Achieve a passing score on the BPS Solid Organ Transplantation Pharmacy Certification Examination.

Recertification is required every seven (7) years and can be accomplished by:

  • Earning 100 hours of continuing education credit provided by a professional development program approved by BPS; or
  • Achieving a passing score on the BPS Solid Organ Transplantation Pharmacy Recertification Examination

Becoming BPS board certified enables pharmacists to:

  • Provide more comprehensive and complex patient care
  • Be prepared to step into pharmacy’s evolving position on the multidisciplinary treatment team
  • Experience increased recognition by other healthcare professionals, employers, patients and insurers
  • Improve their standing in a competitive employment market

Board certification through the Board of Pharmacy Specialties® is the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels. Through the rigorous examination standards mandated by the Board of Pharmacy Specialties®, the BPS board certified pharmacist is uniquely trained and educated to meet the continually expanding expectations of other healthcare team members and the specialized needs of the patients they serve.

Our intent is to offer the first examination in Fall, 2020. The tentative start date for the initial application period will be early May, 2020.

To maintain its strict, independent standards for certification, BPS does NOT provide review information, preparatory courses, or study guides. However, such materials may be available from outside organizations, state or local professional associations and colleges of pharmacy. Candidates are strongly encouraged to review the Solid Organ Transplantation Pharmacy Content Outline published on this website.